Type 1 Diabetes prevention trial with the antigen-specific immunotherapy Diamyd® approved to start – Marketscreener.com
The Swedish Medical Products Agency and the Ethical Review Authority have approved the start of DiaPrecise, an open-label prevention trial with the antigen-specific immunotherapy Diamyd®. The trial will evaluate the…